For many decades, basic and preclinical cancer research has been based on the use of established, commercially available cell lines, originally derived from patients' samples but adapted to grow indefinitely in artificial culture conditions, and on xenograft models developed by injection of these cells in immunocompromised animals [...].
Patient-derived cancer models
Di Renzo M. F.
First
;Corso S.
Last
2020-01-01
Abstract
For many decades, basic and preclinical cancer research has been based on the use of established, commercially available cell lines, originally derived from patients' samples but adapted to grow indefinitely in artificial culture conditions, and on xenograft models developed by injection of these cells in immunocompromised animals [...].
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
cancers-12-03779-v2.pdf
Accesso aperto
Tipo di file:
PDF EDITORIALE
Dimensione
189.64 kB
Formato
Adobe PDF
|
189.64 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
